EnsoData Raises $20M to Expand AI-Powered Sleep Solutions
This new capital will enable EnsoData to accelerate adoption of its AI-powered sleep medicine solutions.
Read MoreThis new capital will enable EnsoData to accelerate adoption of its AI-powered sleep medicine solutions.
Read MoreAge-related differences may be due to a decline in adenosine receptors.
Read MoreAcknowledging the increasing popularity of kids taking melatonin supplements, an International Pediatric Sleep Association task force has provided real-world recommendations for the use of the medication in typically-developing children.
Read MoreA blood test in people with idiopathic REM sleep behavior disorder could help predict the development of dementia years before symptoms appear, a study suggests.
Read MoreGetting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behavior or pathological gambling – not so common.
Read More